Related Experiment Video

Updated: Feb 14, 2026

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

3.8K

Inflammation NODs to Antagonists of RIP2-XIAP Interaction

Shiyu Xia1, Tian-Min Fu1, Hao Wu1

  • 1Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA.

Molecular Cell
|February 18, 2018
PubMed

Insights

Dysregulated innate immunity causes inflammation. A new strategy disrupts the RIP2-XIAP interaction in NOD2 signaling to combat inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Innate immunity is essential for host defense against pathogens.
  • Aberrant activation of signaling pathways, particularly NOD2-mediated signaling, can lead to pathological inflammation and autoimmune diseases.
  • The receptor-interacting protein 2 (RIP2) kinase and X-linked inhibitor of apoptosis protein (XIAP) are key components in NOD2 signaling.

Purpose of the Study:

  • To investigate the role of the RIP2-XIAP interaction in NOD2-mediated inflammatory signaling.
  • To develop a therapeutic strategy targeting the RIP2-XIAP interaction to control inflammatory diseases.

Main Methods:

  • Utilized biochemical assays to analyze the RIP2-XIAP interaction.
  • Employed cell-based models of NOD2-mediated signaling.
  • Investigated the impact of disrupting the RIP2-XIAP interaction on downstream inflammatory responses.

Main Results:

  • Demonstrated that the interaction between RIP2 and XIAP is critical for NOD2-induced signaling.
  • Showcased that disrupting this interaction effectively reduces inflammatory cytokine production.
  • Identified a potential therapeutic target for managing inflammatory conditions.

Conclusions:

  • The RIP2-XIAP interaction is a key node in NOD2-mediated inflammatory signaling.
  • Targeting this interaction offers a promising strategy for the treatment of inflammatory diseases.
  • Further research into RIP2-XIAP modulators could lead to novel anti-inflammatory therapies.

More Related Videos

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

13.2K
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

16.2K

Related Concept Videos

Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K
Inflammation01:38

Inflammation

Overview
62.5K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
993
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
Cholinergic Antagonists: Pharmacological Actions01:28

Cholinergic Antagonists: Pharmacological Actions

Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.0K